Evidence map›Paper›PMID 32446876›Full record

ArticleMolecular metabolism2020

Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high-fat diet.

Joely A Kellard, Nils J G Rorsman, Thomas G Hill, Sarah L Armour, Martijn van de Bunt, Patrik Rorsman, Jakob G Knudsen, Linford J B Briant

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Dehydration-induced AVP stimulates glucagon release and ketogenesis.American journal of physiology. Endocrinology and metabolism · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Joely A KellardOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, Churchill Hospital, Oxford OX3 7LE, UK.
Nils J G RorsmanOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, Churchill Hospital, Oxford OX3 7LE, UK.
Thomas G HillOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, Churchill Hospital, Oxford OX3 7LE, UK.
Sarah L ArmourSection for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Denmark.
Martijn van de BuntDepartment of Bioinformatics and Data Mining, Novo Nordisk A/S, Maaloev, Denmark.
Patrik RorsmanOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, Churchill Hospital, Oxford OX3 7LE, UK; Department of Neuroscience and Physiology, University of Göteborg, Box 430, SE40530 Göteborg, Sweden; Oxford National Institute for Health Research, Biomedical Research Centre, Churchill Hospital, Oxford OX3 7LE, UK.
Jakob G KnudsenOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, Churchill Hospital, Oxford OX3 7LE, UK; Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Denmark. Electronic address: jgknudsen@bio.ku.dk.
Linford J B BriantOxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, Churchill Hospital, Oxford OX3 7LE, UK; Department of Computer Science, University of Oxford, Oxford OX1 3QD, UK. Electronic address: linford.briant@ocdem.ox.ac.uk.
Churchill Hospital · GBUniversity of Copenhagen · DKNovo Nordisk (Denmark) · DK

Funding

Wellcome Trust 095531Wellcome Trust 095531/Z/11/ZWellcome Trust 201325/Z/16/ZWellcome Trust 884655
6 · The paper itself

Abstract

objectivesElevated plasma glucagon is an early symptom of diabetes, occurring in subjects with impaired glucose regulation. Here, we explored alpha-cell function in female mice fed a high-fat diet (HFD).

methodsFemale mice expressing the Ca

resultsIn HFD-fed mice, fed plasma glucagon levels were increased and glucagon secretion from isolated islets and in the perfused mouse pancreas was also elevated. In mice fed a CTL diet, increasing glucose reduced intracellular Ca

conclusionsThese findings suggest that reduced delta-cell function, combined with intrinsic changes in alpha-cells including sensitivity to somatostatin, accounts for the hyperglucagonaemia in mice fed a HFD.

Indexed as

AnimalsBlood GlucoseDiet, High-FatFemaleGlucagonGlucagon-Secreting CellsGlucoseInsulinInsulin-Secreting CellsInsulin SecretionIslets of LangerhansMiceMice, Inbred C57BLSomatostatinSomatostatin-Secreting CellsBlood GlucoseGlucagonGlucoseInsulinSomatostatinAlpha cellCalciumDelta cellDiabetesHigh fat dietHyperglucagonemiaInsulin toleranceIslet of LangerhansParacrineSomatostatin

Identifiers

PMID32446876
PMCPMC7322681
OpenAlexW3024746822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.